Quantcast
Last updated on April 18, 2014 at 11:57 EDT
UCSF Launches Groundbreaking Online Registry To Drive Brain

UCSF Launches Groundbreaking Online Registry To Drive Brain Disease Research

Laura Kurtzman, UC San Francisco Brain Health Registry Brings Promise of Faster, Better Clinical Trials, New Treatments A new online project led by researchers at UC San Francisco promises to dramatically cut the time and cost of conducting...

Latest Pharmaceutical sciences Stories

2014-04-17 23:14:05

On March 26, the FDA announced the recall of Bella Vi products by Pure Edge Nutrition because they contain undeclared drug ingredients. In light of this news, AttorneyOne, a recognized authority on law, updated the website providing detailed information to consumers. San Diego, CA (PRWEB) April 16, 2014 AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest information from the FDA on safety alerts for weight loss dietary supplements. As the FDA...

2014-04-17 23:05:28

Number of Lawsuits Pending Against Manufacturer Approaches 6,000 DALLAS (PRWEB) April 17, 2014 National law firm Baron & Budd reports that the number of lawsuits against the manufacturer of GranuFlo continues to increase. The lawsuits stem from patients who suffered adverse health effects after undergoing dialysis treatment where the product was used. Baron and Budd shareholders currently serve on the leadership committee, known as the Plaintiffs’ Steering Committee, in the...

2014-04-17 23:00:44

Matt Osterhaus to Focus on Provider Status and Leadership Development Des Moines, IA (PRWEB) April 17, 2014 OutcomesMTM™ Board member and new President of APhA, Matt Osterhaus, BSPharm, FASCP, FAPhA, both found and offered inspiration at APhA2014. Osterhaus said all the positive energy coming out of pharmacy keeps his battery charged. He celebrated the beginning of his term at a dinner with close friends, colleagues and mentors. “It was extremely rewarding and humbling that people...

2014-04-17 16:27:20

DUBLIN, April 17, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT), a leading global specialty pharmaceutical company, today announced that it has entered into agreements with Akorn, Inc. and Hi-Tech Pharmacal Co. Inc. to purchase four currently marketed products and one product under development for cash consideration. The closing of the purchase agreements are contingent upon the consummation of Akorn's acquisition of Hi-Tech. Financial terms of the agreements were not disclosed. The...

2014-04-17 16:26:44

SHERBROOKE, Quebec and BIRMINGHAM, Ala., April 17, 2014 /PRNewswire-USNewswire/ -- Cyclenium Pharma Inc., an emerging pharmaceutical company specializing in the research and development of novel drug candidates based on proprietary macrocyclic chemistry, today announced the signing of a discovery and co-development agreement with Southern Research Institute, a not-for-profit 501(c)(3) scientific research organization founded in 1941. The collaboration will utilize Cyclenium's...

2014-04-17 16:24:27

LOS ANGELES, April 17, 2014 /PRNewswire/ -- Verde Media Group Inc. (OTC: VMGI) Tune in tomorrow Friday the 18(th), with Alan and Adam Scavone for another addition to the Pot-Cast. This week will focus on drug policy and reform and how it relates to our nation's health. Adam Scavone is the co-founder and director of the New York Cannabis Alliance. He is a 2013 graduate of Brooklyn Law School, where he founded a chapter of Students for Sensible Drug Policy, and holds a master degree...

2014-04-17 11:28:47

Dermatologists with access to free drug samples are more likely than those without access to samples to write prescriptions for drugs that are more expensive, according to a study by researchers at the Stanford University School of Medicine. Although studies have shown that most physicians do not believe that the availability of free samples affects their behavior or recommendations for patients, the researchers found that the average retail cost of the prescriptions written by...

2014-04-17 08:28:00

RIDGEFIELD, Conn., April 17, 2014 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) and European Commission (EC) have granted Orphan Drug Designation to volasertib for acute myeloid leukemia (AML). Volasertib is currently being evaluated in a Phase III clinical trial for the treatment of patients aged 65 or older, with previously untreated AML, who are ineligible for intensive remission induction therapy....

2014-04-17 08:27:47

BOSTON, April 17, 2014 /PRNewswire/ -- Columbia Laboratories, Inc. (Nasdaq: CBRX) will hold a conference call on April 29, 2014, to discuss financial results of the first quarter ended March 31, 2014. Frank Condella, President and Chief Executive Officer, and Jonathan Lloyd Jones, Vice President and Chief Financial Officer of Columbia Laboratories, will host the call as follows: Date: Tuesday, April 29, 2014 Time: 8:30 am EDT...

2014-04-17 00:21:08

CHENGDU, China, April 16, 2014 /PRNewswire/ -- Tianyin Pharmaceutical Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in the development and sale of patented biopharmaceutical medicine, modernized traditional Chinese medicine (TCM), branded generics, and active pharmaceutical ingredients (API), updated regarding the recent progress of the Jiangchuan Macrolide Facility (JCM). JCM has developed a new line of Azithromycin (Azi) API products that support steady monthly...


Latest Pharmaceutical sciences Reference Libraries

Phytotherapy Research
2012-05-01 10:17:25

Phytotherapy Research is a monthly peer-reviewed scientific journal publishing original research papers, short communications, reviews, and letters on medicinal plant research. Topics include pharmacology, toxicology, and the clinical applications of herbs and natural products in medicine, from case histories to clinical trials, including studies of herb-drug interactions and other aspects of the safety of herbal medicines. Short communications dealing with the pharmacology and screening...

More Articles (1 articles) »